Delivery Order SPE2DB24D9238-SPE2DB25FDQZN
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,783.55 by the Defense Logistics Agency on July 25, 2025, for YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,701.30 for YF-VAX 1 dose vials on June 24, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 million single-award contract valid through November 2026. The award carries no set-aside designation, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $55,671 by the Defense Logistics Agency (DLA) on September 5, 2025. The order is for YF-VAX 1 Dose Vials, a yellow fever vaccine product, with an ultimate completion date of September 26, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on its merits in the broader federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,335.28 for YF-VAX 1 Dose Vials by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 7, 2025, represents a specific pharmaceutical product fulfillment under the company's existing contract vehicle. The award carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,226.84 by the Defense Logistics Agency on August 26, 2025, for the supply of YF-VAX 1 Dose Vials. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, carries no set-aside designation. The award leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,226.84 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, carries no set-aside designation. The contract represents a direct fulfillment order issued under DMS Pharmaceutical Group's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of YF-VAX 1 Dose Vials. This delivery order, valued at $2,783.55 with an ultimate completion date of August 11, 2025, was issued without a set-aside designation. The contract represents a discrete delivery against DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $55,671.00 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of YF-VAX 1 Dose Vials. The contract carries a firm fixed price structure with an ultimate completion date of September 8, 2025, and was awarded without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order valued at $5,567.10 from the Defense Logistics Agency for YF-VAX 1 Dose Vials. Awarded on July 31, 2025, with an ultimate completion date of August 21, 2025, this firm fixed-price delivery order represents a direct procurement for yellow fever vaccine supplies required by the Department of Defense. The contract was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $55,671 by the Defense Logistics Agency on June 24, 2025, for the supply of YF-VAX 1 Dose Vials. The contract utilizes firm fixed-price pricing with no set-aside designation and is scheduled for completion by July 16, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQZNDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on August 26, 2025, for YF-VAX 1 dose vials with a ceiling value of $2,783.55. This firm fixed-price delivery order, which has no set-aside designation, is expected to be completed by September 17, 2025, with performance at the company's Park Ridge facility. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's SPE2DB program, a $499.99 billion contract vehicle valid through November 2026 that enables the agency to issue delivery orders for pharmaceutical supplies supporting military health facilities worldwide. YF-VAX is a yellow fever vaccine administered as a single-dose vial injection, commonly procured by the Department of Defense for military personnel and eligible beneficiaries requiring yellow fever immunization for overseas deployment or travel. This delivery order represents a routine pharmaceutical procurement through the established DLA framework, leveraging DMS Pharmaceutical Group's capabilities as a critical distributor of prescription drugs, biologics, vaccines, and medical consumables throughout the federal healthcare supply chain. The company has maintained consistent success in competing for federal pharmaceutical contracts without set-aside designations, demonstrating its competitive positioning within the commercial pharmaceutical wholesale market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/26/25 |